Suppr超能文献

提高重点人群的识别率以提高乙肝检测率,2012年。

Improving the identification of priority populations to increase hepatitis B testing rates, 2012.

作者信息

van Gemert Caroline, Wang Julie, Simmons Jody, Cowie Benjamin, Boyle Douglas, Stoove Mark, Enright Chris, Hellard Margaret

机构信息

Centre for Population Health, Burnet Institute, Melbourne, Australia.

Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.

出版信息

BMC Public Health. 2016 Feb 1;16:95. doi: 10.1186/s12889-016-2716-7.

Abstract

BACKGROUND

It is estimated that over 40 % of the 218,000 people with chronic hepatitis B (CHB) in Australia in 2011 are undiagnosed. A disproportionate number of those with undiagnosed infection were born in the Asia-Pacific region. Undiagnosed CHB can lead to ongoing transmission and late diagnosis limits opportunities to prevent progression to hepatocellular carcinoma (HCC) and cirrhosis. Strategies are needed to increase testing for hepatitis B virus (HBV) (including culturally and linguistically diverse communities, Aboriginal and/or Torres Strait Islander (Indigenous) people and people who inject drugs). General practitioners (GPs) have a vital role in increasing HBV testing and the timely diagnosis CHB. This paper describes the impact of a GP-based screening intervention to improve CHB diagnosis among priority populations in Melbourne, Australia.

METHODS

A non-randomised, pre-post intervention study was conducted between 2012 and 2013 with three general practices in Melbourne, Australia. Using clinic electronic health records three priority populations known to be at increased CHB risk in Australia (1: Asian-born patients or patients of Asian ethnicity living in Australia; 2: Indigenous people; or 3): people with a history of injecting drugs were identified and their HBV status recorded. A random sample were then invited to attend their GP for HBV testing and/or vaccination. Baseline and follow-up electronic data collection identified patients that subsequently had a consultation and HBV screening test and/or vaccination.

RESULTS

From a total of 33,297 active patients, 2674 (8 %) were identified as a priority population at baseline; 2275 (85.1 %) of these patients had unknown HBV status from which 338 (14.0 %) were randomly sampled. One-fifth (n = 73, 21.6 %) of sampled patients subsequently had a GP consultation during the study period; only four people (5.5 %) were subsequently tested for HBV (CHB detected in n = 1) and none were vaccinated against HBV.

CONCLUSION

CHB infection is an important long-term health issue in Australia and strategies to increase appropriate and timely testing are required. The study was effective at identifying whether Asian-born patients and patients of Asian had been tested or vaccinated for HBV; however the intervention was not effective at increasing HBV testing.

摘要

背景

据估计,2011年澳大利亚21.8万慢性乙型肝炎(CHB)患者中,超过40%未被诊断出来。未被诊断出感染的人群中,出生于亚太地区的人数比例过高。未被诊断出的慢性乙型肝炎会导致病毒持续传播,而诊断延迟会减少预防发展为肝细胞癌(HCC)和肝硬化的机会。因此需要采取策略来增加乙型肝炎病毒(HBV)检测(包括不同文化和语言背景的社区、原住民和/或托雷斯海峡岛民(原住民)以及注射吸毒者)。全科医生(GP)在增加HBV检测和及时诊断CHB方面起着至关重要的作用。本文描述了一项基于全科医生的筛查干预措施对改善澳大利亚墨尔本重点人群CHB诊断的影响。

方法

2012年至2013年期间,在澳大利亚墨尔本的三家全科诊所进行了一项非随机的干预前后研究。利用诊所电子健康记录,确定了澳大利亚已知CHB风险增加的三类重点人群(1:出生于亚洲的患者或居住在澳大利亚的亚裔患者;2:原住民;3:有注射吸毒史的人),并记录了他们的HBV状态。然后随机抽取一部分人邀请其前往全科医生处进行HBV检测和/或接种疫苗。通过基线和随访电子数据收集,确定随后进行了咨询以及HBV筛查检测和/或接种疫苗的患者。

结果

在总共33297名活跃患者中,2674名(8%)在基线时被确定为重点人群;这些患者中有

相似文献

1
Improving the identification of priority populations to increase hepatitis B testing rates, 2012.
BMC Public Health. 2016 Feb 1;16:95. doi: 10.1186/s12889-016-2716-7.
2
Measuring quality of hepatitis B care in a remote Australian Aboriginal community: opportunities for improvement.
Intern Med J. 2022 Aug;52(8):1347-1353. doi: 10.1111/imj.15349. Epub 2022 May 31.
5
Mother-to-child transmission of hepatitis B in Far North Queensland, 2013-2023.
Commun Dis Intell (2018). 2025 Mar 25;49. doi: 10.33321/cdi.2025.49.026.
7
Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
J Gastroenterol Hepatol. 2010 Apr;25(4):657-63. doi: 10.1111/j.1440-1746.2009.06167.x.

本文引用的文献

1
The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment.
Aust N Z J Public Health. 2015 Jun;39(3):255-9. doi: 10.1111/1753-6405.12345. Epub 2015 Feb 25.
2
Addressing viral hepatitis in the opiate substitution setting: an integrated nursing model of care.
J Gastroenterol Hepatol. 2015 Mar;30 Suppl 2:6-11. doi: 10.1111/jgh.12864.
4
Improving ethnocultural data to inform public health responses to communicable diseases in Australia.
Western Pac Surveill Response J. 2014 May 19;5(2):1-4. doi: 10.5365/WPSAR.2014.5.1.011. eCollection 2014 Apr-Jun.
5
General practice ethnicity data: evaluation of a tool.
J Prim Health Care. 2014 Mar 1;6(1):49-55.
6
Completeness and usability of ethnicity data in UK-based primary care and hospital databases.
J Public Health (Oxf). 2014 Dec;36(4):684-92. doi: 10.1093/pubmed/fdt116. Epub 2013 Dec 8.
7
A validation of the use of names to screen for risk of chronic hepatitis B in Victoria, Australia, 2001 to 2010.
Euro Surveill. 2013 Nov 21;18(47):20638. doi: 10.2807/1560-7917.es2013.18.47.20638.
8
The burden of chronic hepatitis B virus infection in Australia, 2011.
Aust N Z J Public Health. 2013 Oct;37(5):416-22. doi: 10.1111/1753-6405.12049. Epub 2013 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验